The Phase 2 data (14.8% weight loss at 13 weeks with reported muscle preservation) are remarkable if confirmed, suggesting rapid, substantial weight loss that approaches semaglutide's 68-week results in just a fraction of the time
Oral Semaglutide works similarly to the injectable form, helping with insulin secretion, reduced glucagon levels and appetite control
Once a patient is active, chat in the portal is 24/7 with an AI front end that routes to a human if it cannot answer
doi: 10.1016/j.diabres.2005.10.005 29 RetnakaranRQiYGoranMIHamiltonJK
Mounjaro (tirzepatide), a groundbreaking injectable medication, has gained significant attention for its effectiveness in both blood sugar control and weight management
Hahn J, Hoffmann TK, Bock B, Nordmann-Kleiner M, Trainotti S, Greve J